Vicarious Surgical (RBOT) Amortization of Deferred Charges (2021 - 2022)
Vicarious Surgical's (RBOT) quarterly Amortization of Deferred Charges came in at $50000.0 in Q4 2022, up 433.33% year-over-year from $9375.0 in Q4 2021, and up 525.0% quarter-over-quarter from $8000.0 in Q3 2022.
Powered by 
Analysis
Vicarious Surgical (RBOT) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends
Vicarious Surgical (RBOT) has reported Amortization of Deferred Charges for 2 consecutive years, with $50000.0 the latest figure, recorded in Q4 2022.
- On a quarterly basis, Amortization of Deferred Charges rose 433.33% year-over-year to $50000.0 in Q4 2022; TTM through Dec 2022 was $75000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $75000.0, up 257.14% from the prior year.
- Amortization of Deferred Charges was $50000.0 for Q4 2022 at Vicarious Surgical, up from $8000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $50000.0 in Q4 2022 and troughed at -$15000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | -15,000.00 |
| Sep 30, 2021 | 27,000.00 |